|
|
||||||||
The Journal of Immunology, Vol 151, Issue 1 277-283, Copyright © 1993 by American Association of Immunologists
ARTICLES |
HF Staats and RN Lausch
Department of Microbiology and Immunology, University of South Alabama College of Medicine, Mobile 36688.
HSV-1 topical infection on the murine cornea can induce herpetic stromal keratitis (HSK), a T cell-mediated inflammatory response that results in blindness. To begin to decipher the molecular interactions involved in this infection, extracts of infected corneas were assayed for the presence of seven different cytokines by ELISA. The most prominent cytokines detected were IL-1 alpha and IL-6. Both were elevated by day 2 after infection, reached peak levels of 82 and 538 pg/cornea, respectively, at day 10, and then diminished over the next 10 days. In contrast, TNF-alpha concentrations were not elevated over that seen in uninfected corneas at any time during the 20-day observation period. IFN-gamma and granulocyte-macrophage CSF corneal concentrations were below the sensitivity of the assay. We investigated whether passive transfer of antibody to viral glycoprotein D, which prevents HSK, influenced the production of IL-1 alpha and IL-6. It was found that corneal concentrations of IL-1 alpha were reduced threefold and IL-6 was undetectable at day 10 in the antibody-treated hosts. The levels of IL-10 and IL-4 in uninfected control and antibody-treated hosts were also monitored. Neither of these two regulatory cytokines was associated with HSK development or effective antibody therapy. Naive corneas cultured in vitro spontaneously produced IL-1 and IL-6, indicating that cells resident in the cornea had the ability to synthesize these proinflammatory cytokines. Collectively, our results imply that IL-1 alpha and IL-6 may be important contributors to the development of HSK pathogenesis.
This article has been cited by other articles:
![]() |
S. J. Molesworth-Kenyon, R. Yin, J. E. Oakes, and R. N. Lausch IL-17 receptor signaling influences virus-induced corneal inflammation J. Leukoc. Biol., February 1, 2008; 83(2): 401 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nakao, Y. Hata, M. Miura, K. Noda, Y. N. Kimura, S. Kawahara, T. Kita, T. Hisatomi, T. Nakazawa, Y. Jin, et al. Dexamethasone Inhibits Interleukin-1{beta}-Induced Corneal Neovascularization: Role of Nuclear Factor-{kappa}B-Activated Stromal Cells in Inflammatory Angiogenesis Am. J. Pathol., September 1, 2007; 171(3): 1058 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Biswas, K. Banerjee, M. Zheng, and B. T. Rouse Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein J. Leukoc. Biol., October 1, 2004; 76(4): 868 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Suvas, A. K. Azkur, B. S. Kim, U. Kumaraguru, and B. T. Rouse CD4+CD25+ Regulatory T Cells Control the Severity of Viral Immunoinflammatory Lesions J. Immunol., April 1, 2004; 172(7): 4123 - 4132. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Biswas, K. Banerjee, B. Kim, and B. T. Rouse Mice Transgenic for IL-1 Receptor Antagonist Protein Are Resistant to Herpetic Stromal Keratitis: Possible Role for IL-1 in Herpetic Stromal Keratitis Pathogenesis J. Immunol., March 15, 2004; 172(6): 3736 - 3744. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamagami, S. Yamagami, T. Inoki, S. Amano, and K. Miyata The Effects of Proinflammatory Cytokines on Cytokine-Chemokine Gene Expression Profiles in the Human Corneal Endothelium Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 514 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Fenton, S. Molesworth-Kenyon, J. E. Oakes, and R. N. Lausch Linkage of IL-6 with Neutrophil Chemoattractant Expression in Virus-Induced Ocular Inflammation Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 737 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Heiligenhaus, D. Bauer, D. Meller, K.-P. Steuhl, and S. C. G. Tseng Improvement of HSV-1 Necrotizing Keratitis with Amniotic Membrane Transplantation Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 1969 - 1974. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-T. Yan, M. Zhuang, J. E. Oakes, and R. N. Lausch Autocrine action of IL-10 suppresses proinflammatory mediators and inflammation in the HSV-1-infected cornea J. Leukoc. Biol., January 1, 2001; 69(1): 149 - 157. [Abstract] [Full Text] |
||||
![]() |
S. Noisakran and D. J. J. Carr Plasmid DNA Encoding IFN-{alpha}1 Antagonizes Herpes Simplex Virus Type 1 Ocular Infection Through CD4+ and CD8+ T Lymphocytes J. Immunol., June 15, 2000; 164(12): 6435 - 6443. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. L. Rudner, K. A. Kernacki, R. P. Barrett, and L. D. Hazlett Prolonged Elevation of IL-1 in Pseudomonas aeruginosa Ocular Infection Regulates Macrophage-Inflammatory Protein-2 Production, Polymorphonuclear Neutrophil Persistence, and Corneal Perforation J. Immunol., June 15, 2000; 164(12): 6576 - 6582. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Keadle, N. Usui, K. A. Laycock, J. K. Miller, J. S. Pepose, and P. M. Stuart IL-1 and TNF-{alpha} Are Important Factors in the Pathogenesis of Murine Recurrent Herpetic Stromal Keratitis Invest. Ophthalmol. Vis. Sci., January 1, 2000; 41(1): 96 - 102. [Abstract] [Full Text] |
||||
![]() |
N. Cole, S. Bao, M. Willcox, and A. J. Husband Expression of Interleukin-6 in the Cornea in Response to Infection with Different Strains of Pseudomonas aeruginosa Infect. Immun., May 1, 1999; 67(5): 2497 - 2502. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yamada, M. R. Dana, S.-N. Zhu, P. Alard, and J. W. Streilein Interleukin 1 Receptor Antagonist Suppresses Allosensitization in Corneal Transplantation Arch Ophthalmol, October 1, 1998; 116(10): 1351 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen and R. L. Hendricks B7 Costimulatory Requirements of T Cells at an Inflammatory Site J. Immunol., May 15, 1998; 160(10): 5045 - 5052. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Nicholson and D. P. Hajjar Herpesviruses in Atherosclerosis and Thrombosis : Etiologic Agents or Ubiquitous Bystanders? Arterioscler. Thromb. Vasc. Biol., March 1, 1998; 18(3): 339 - 348. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |